UM Ventures News
![Remedy Pharmaceuticals Remedy Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/RemedyNew.jpg?itok=-eidzljv)
Remedy Pharmaceuticals Announces Additional Results From Phase 2 CNS-Related Edema Study of CIRARA™
Tuesday, February 23, 2016
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Clinical Trial
Tuesday, January 19, 2016
Harpoon Medical could sell to new investor, Edwards Lifesciences
Tuesday, December 15, 2015
PaxVax, Inc. Announces $105 Million Investment from Cerberus Capital Management
Wednesday, December 9, 2015
![Remedy Pharmaceuticals Remedy Pharmaceuticals](https://www.umventures.org/sites/default/files/styles/medium/public/RemedyNew.jpg?itok=-eidzljv)
Remedy Pharmaceuticals Completes $9 Million Financing
Tuesday, December 1, 2015
School of Medicine Researchers Work to Develop GammaPod for Breast Cancer Therapy
Tuesday, November 24, 2015
![Profectus logo Profectus logo](https://www.umventures.org/sites/default/files/styles/medium/public/Profectus_0.png?itok=asJ3JGQh)
Profectus Preclinical Data of Multi-Component Vaccine Provides Protection Against Ebola & Marburg Virus
Thursday, November 19, 2015